Copyright Reports & Markets. All rights reserved.

Global Gene Mutagenesis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene Mutagenesis Service by Type
    • 1.3.1 Overview: Global Gene Mutagenesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Gene Mutagenesis Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Site-Directed Mutagenesis
    • 1.3.4 Random Mutagenesis
  • 1.4 Global Gene Mutagenesis Service Market by Application
    • 1.4.1 Overview: Global Gene Mutagenesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Research
    • 1.4.4 Others
  • 1.5 Global Gene Mutagenesis Service Market Size & Forecast
  • 1.6 Global Gene Mutagenesis Service Market Size and Forecast by Region
    • 1.6.1 Global Gene Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Gene Mutagenesis Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Gene Mutagenesis Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Gene Mutagenesis Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Gene Mutagenesis Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Gene Mutagenesis Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Gene Mutagenesis Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermofisher
    • 2.1.1 Thermofisher Details
    • 2.1.2 Thermofisher Major Business
    • 2.1.3 Thermofisher Gene Mutagenesis Service Product and Solutions
    • 2.1.4 Thermofisher Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermofisher Recent Developments and Future Plans
  • 2.2 Azenta Life Sciences
    • 2.2.1 Azenta Life Sciences Details
    • 2.2.2 Azenta Life Sciences Major Business
    • 2.2.3 Azenta Life Sciences Gene Mutagenesis Service Product and Solutions
    • 2.2.4 Azenta Life Sciences Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Azenta Life Sciences Recent Developments and Future Plans
  • 2.3 Creative Biogene
    • 2.3.1 Creative Biogene Details
    • 2.3.2 Creative Biogene Major Business
    • 2.3.3 Creative Biogene Gene Mutagenesis Service Product and Solutions
    • 2.3.4 Creative Biogene Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Creative Biogene Recent Developments and Future Plans
  • 2.4 Charles River
    • 2.4.1 Charles River Details
    • 2.4.2 Charles River Major Business
    • 2.4.3 Charles River Gene Mutagenesis Service Product and Solutions
    • 2.4.4 Charles River Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Charles River Recent Developments and Future Plans
  • 2.5 ACGT
    • 2.5.1 ACGT Details
    • 2.5.2 ACGT Major Business
    • 2.5.3 ACGT Gene Mutagenesis Service Product and Solutions
    • 2.5.4 ACGT Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 ACGT Recent Developments and Future Plans
  • 2.6 Vectorbuilder
    • 2.6.1 Vectorbuilder Details
    • 2.6.2 Vectorbuilder Major Business
    • 2.6.3 Vectorbuilder Gene Mutagenesis Service Product and Solutions
    • 2.6.4 Vectorbuilder Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Vectorbuilder Recent Developments and Future Plans
  • 2.7 Creative Biolabs
    • 2.7.1 Creative Biolabs Details
    • 2.7.2 Creative Biolabs Major Business
    • 2.7.3 Creative Biolabs Gene Mutagenesis Service Product and Solutions
    • 2.7.4 Creative Biolabs Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Creative Biolabs Recent Developments and Future Plans
  • 2.8 Bio Basic
    • 2.8.1 Bio Basic Details
    • 2.8.2 Bio Basic Major Business
    • 2.8.3 Bio Basic Gene Mutagenesis Service Product and Solutions
    • 2.8.4 Bio Basic Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bio Basic Recent Developments and Future Plans
  • 2.9 Applied Biological Materials
    • 2.9.1 Applied Biological Materials Details
    • 2.9.2 Applied Biological Materials Major Business
    • 2.9.3 Applied Biological Materials Gene Mutagenesis Service Product and Solutions
    • 2.9.4 Applied Biological Materials Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Applied Biological Materials Recent Developments and Future Plans
  • 2.10 NovoPro Bioscience
    • 2.10.1 NovoPro Bioscience Details
    • 2.10.2 NovoPro Bioscience Major Business
    • 2.10.3 NovoPro Bioscience Gene Mutagenesis Service Product and Solutions
    • 2.10.4 NovoPro Bioscience Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 NovoPro Bioscience Recent Developments and Future Plans
  • 2.11 Abace-Biology
    • 2.11.1 Abace-Biology Details
    • 2.11.2 Abace-Biology Major Business
    • 2.11.3 Abace-Biology Gene Mutagenesis Service Product and Solutions
    • 2.11.4 Abace-Biology Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Abace-Biology Recent Developments and Future Plans
  • 2.12 Sangon Biotech
    • 2.12.1 Sangon Biotech Details
    • 2.12.2 Sangon Biotech Major Business
    • 2.12.3 Sangon Biotech Gene Mutagenesis Service Product and Solutions
    • 2.12.4 Sangon Biotech Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sangon Biotech Recent Developments and Future Plans
  • 2.13 Genscript
    • 2.13.1 Genscript Details
    • 2.13.2 Genscript Major Business
    • 2.13.3 Genscript Gene Mutagenesis Service Product and Solutions
    • 2.13.4 Genscript Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Genscript Recent Developments and Future Plans
  • 2.14 Beijing Tsingke Biotech
    • 2.14.1 Beijing Tsingke Biotech Details
    • 2.14.2 Beijing Tsingke Biotech Major Business
    • 2.14.3 Beijing Tsingke Biotech Gene Mutagenesis Service Product and Solutions
    • 2.14.4 Beijing Tsingke Biotech Gene Mutagenesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Beijing Tsingke Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene Mutagenesis Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Gene Mutagenesis Service by Company Revenue
    • 3.2.2 Top 3 Gene Mutagenesis Service Players Market Share in 2025
    • 3.2.3 Top 6 Gene Mutagenesis Service Players Market Share in 2025
  • 3.3 Gene Mutagenesis Service Market: Overall Company Footprint Analysis
    • 3.3.1 Gene Mutagenesis Service Market: Region Footprint
    • 3.3.2 Gene Mutagenesis Service Market: Company Product Type Footprint
    • 3.3.3 Gene Mutagenesis Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene Mutagenesis Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Gene Mutagenesis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Gene Mutagenesis Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Gene Mutagenesis Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Gene Mutagenesis Service Consumption Value by Type (2021-2032)
  • 6.2 North America Gene Mutagenesis Service Market Size by Application (2021-2032)
  • 6.3 North America Gene Mutagenesis Service Market Size by Country
    • 6.3.1 North America Gene Mutagenesis Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Gene Mutagenesis Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Gene Mutagenesis Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Gene Mutagenesis Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Gene Mutagenesis Service Market Size by Country
    • 7.3.1 Europe Gene Mutagenesis Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Gene Mutagenesis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Mutagenesis Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Gene Mutagenesis Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Gene Mutagenesis Service Market Size by Region
    • 8.3.1 Asia-Pacific Gene Mutagenesis Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Gene Mutagenesis Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Gene Mutagenesis Service Consumption Value by Type (2021-2032)
  • 9.2 South America Gene Mutagenesis Service Consumption Value by Application (2021-2032)
  • 9.3 South America Gene Mutagenesis Service Market Size by Country
    • 9.3.1 South America Gene Mutagenesis Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Gene Mutagenesis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Mutagenesis Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Gene Mutagenesis Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Gene Mutagenesis Service Market Size by Country
    • 10.3.1 Middle East & Africa Gene Mutagenesis Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Gene Mutagenesis Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Gene Mutagenesis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Gene Mutagenesis Service Market Drivers
  • 11.2 Gene Mutagenesis Service Market Restraints
  • 11.3 Gene Mutagenesis Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Gene Mutagenesis Service Industry Chain
  • 12.2 Gene Mutagenesis Service Upstream Analysis
  • 12.3 Gene Mutagenesis Service Midstream Analysis
  • 12.4 Gene Mutagenesis Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Gene Mutagenesis Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Gene mutagenesis service refers to service that facilitates the introduction of specific mutations into genes for research or biotechnological purposes, typically used to study gene functions or engineer genetic variants with desired properties.
    This report is a detailed and comprehensive analysis for global Gene Mutagenesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Gene Mutagenesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Gene Mutagenesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Gene Mutagenesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Gene Mutagenesis Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Gene Mutagenesis Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Gene Mutagenesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermofisher, Azenta Life Sciences, Creative Biogene, Charles River, ACGT, Vectorbuilder, Creative Biolabs, Bio Basic, Applied Biological Materials, NovoPro Bioscience, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Gene Mutagenesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Site-Directed Mutagenesis
    Random Mutagenesis
    Market segment by Application
    Pharmaceutical Industry
    Research
    Others
    Market segment by players, this report covers
    Thermofisher
    Azenta Life Sciences
    Creative Biogene
    Charles River
    ACGT
    Vectorbuilder
    Creative Biolabs
    Bio Basic
    Applied Biological Materials
    NovoPro Bioscience
    Abace-Biology
    Sangon Biotech
    Genscript
    Beijing Tsingke Biotech
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Gene Mutagenesis Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Gene Mutagenesis Service, with revenue, gross margin, and global market share of Gene Mutagenesis Service from 2021 to 2026.
    Chapter 3, the Gene Mutagenesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gene Mutagenesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Mutagenesis Service.
    Chapter 13, to describe Gene Mutagenesis Service research findings and conclusion.

    Buy now